The most common (≥ 5%) grade 3/4 AEs with pexidartinib were increased aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) and hypertension. This evidence concerns the gene GPT and hypertensive disorder.